Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 98
Filter
1.
Braz J Med Biol Res ; 52(2): e8103, 2019 Jan 10.
Article in English | MEDLINE | ID: mdl-30652827

ABSTRACT

Dipyrone (metamizole), acting through its main metabolites 4-methyl-amino-antipyrine and 4-amino-antipyrine, has established analgesic, antipyretic, and spasmolytic pharmacological effects, which are mediated by poorly known mechanisms. In rats, intravenously administered dipyrone delays gastric emptying (GE) of liquids with the participation of capsaicin-sensitive afferent fibers. This effect seems to be mediated by norepinephrine originating from the sympathetic nervous system but not from the superior celiac-mesenteric ganglion complex, which activates ß2-adrenoceptors. In rats, in contrast to nonselective non-hormonal anti-inflammatory drugs, dipyrone protects the gastric mucosa attenuating the development of gastric ulcers induced by a number of agents. Clinically, it has been demonstrated that dipyrone is effective in the control of colic-like abdominal pain originating from the biliary and intestinal tracts. Since studies in humans and animals have demonstrated the presence of ß2-adrenoceptors in biliary tract smooth muscle and ß2-adrenoceptor activation has been shown to occur in dipyrone-induced delayed GE, it is likely that this kind of receptors may participate in the reduction of smooth muscle spasm of the sphincter of Oddi induced by dipyrone. There is no evidence that dipyrone may interfere with small bowel and colon motility, and the clinical results of its therapeutic use in intestinal colic appear to be due to its analgesic effect.


Subject(s)
Ampyrone/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antipyrine/pharmacology , Dipyrone/pharmacology , Gastric Emptying/drug effects , Animals , Autonomic Nerve Block , Dipyrone/administration & dosage , Rats , Rats, Wistar
2.
Braz. j. med. biol. res ; 52(2): e8103, 2019.
Article in English | LILACS | ID: biblio-974278

ABSTRACT

Dipyrone (metamizole), acting through its main metabolites 4-methyl-amino-antipyrine and 4-amino-antipyrine, has established analgesic, antipyretic, and spasmolytic pharmacological effects, which are mediated by poorly known mechanisms. In rats, intravenously administered dipyrone delays gastric emptying (GE) of liquids with the participation of capsaicin-sensitive afferent fibers. This effect seems to be mediated by norepinephrine originating from the sympathetic nervous system but not from the superior celiac-mesenteric ganglion complex, which activates β2-adrenoceptors. In rats, in contrast to nonselective non-hormonal anti-inflammatory drugs, dipyrone protects the gastric mucosa attenuating the development of gastric ulcers induced by a number of agents. Clinically, it has been demonstrated that dipyrone is effective in the control of colic-like abdominal pain originating from the biliary and intestinal tracts. Since studies in humans and animals have demonstrated the presence of β2-adrenoceptors in biliary tract smooth muscle and β2-adrenoceptor activation has been shown to occur in dipyrone-induced delayed GE, it is likely that this kind of receptors may participate in the reduction of smooth muscle spasm of the sphincter of Oddi induced by dipyrone. There is no evidence that dipyrone may interfere with small bowel and colon motility, and the clinical results of its therapeutic use in intestinal colic appear to be due to its analgesic effect.


Subject(s)
Animals , Rats , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Ampyrone/pharmacology , Antipyrine/pharmacology , Dipyrone/pharmacology , Gastric Emptying/drug effects , Autonomic Nerve Block , Dipyrone/administration & dosage , Rats, Wistar
3.
Osteoporos Int ; 28(7): 2167-2176, 2017 07.
Article in English | MEDLINE | ID: mdl-28405731

ABSTRACT

Bone marrow adipose tissue has not been studied in patients with inactive inflammatory bowel disease. We found that these patients have preserved marrow adiposity even with low bone mass. Factors involved in bone loss in active disease may have long-lasting effects but do not seem to affect bone marrow adiposity. INTRODUCTION: Reduced bone mass is known to occur at varying prevalence in patients with inflammatory bowel diseases (IBD) because of inflammation, malnutrition, and steroid therapy. Osteoporosis may develop in these patients as the result of an imbalanced relationship between osteoblasts and adipocytes in bone marrow. This study aimed to evaluate for the first time bone mass and bone marrow adipose tissue (BMAT) in a particular subgroup of IBD patients characterized by long-term, steroid-free remission. METHODS: Patients with Crohn's disease (CD; N = 21) and ulcerative colitis (UC; N = 15) and controls (C; N = 65) underwent dual X-ray energy absorptiometry and nuclear magnetic resonance spectroscopy of the L3 lumbar vertebra for BMAT assessment. RESULTS: Both the CD and UC subgroups showed significantly higher proportions of patients than controls with Z-score ≤-2.0 at L1-L4 (C 1.54%; CD 19.05%; UC 20%; p = 0.02), but not at other sites. The proportions of CD patients with a T-score ˂-1.0 at the femoral neck (C 18.46%; CD 47.62%; p = 0.02) and total hip (C 16.92%; CD 42.86%; p = 0.03) were significantly higher than among controls. There were no statistically significant differences between IBD patients and controls regarding BMAT at L3 (C 28.62 ± 8.15%; CD 29.81 ± 6.90%; UC 27.35 ± 9.80%; p = 0.67). CONCLUSIONS: IBD patients in long-term, steroid-free remission may have a low bone mass in spite of preserved BMAT. These findings confirm the heterogeneity of bone disorders in IBD and may indicate that factors involved in bone loss in active disease may have long-lasting effects on these patients.


Subject(s)
Adipose Tissue/pathology , Bone Marrow/pathology , Inflammatory Bowel Diseases/complications , Osteoporosis/etiology , Absorptiometry, Photon/methods , Adult , Bone Density/physiology , Case-Control Studies , Colitis, Ulcerative/complications , Colitis, Ulcerative/pathology , Colitis, Ulcerative/physiopathology , Crohn Disease/complications , Crohn Disease/pathology , Crohn Disease/physiopathology , Female , Femur Neck/physiopathology , Hip Joint/physiopathology , Humans , Inflammatory Bowel Diseases/pathology , Inflammatory Bowel Diseases/physiopathology , Lumbar Vertebrae/physiopathology , Magnetic Resonance Imaging/methods , Male , Middle Aged , Osteoporosis/pathology , Osteoporosis/physiopathology , Young Adult
5.
Eur J Clin Nutr ; 64(8): 845-52, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20485299

ABSTRACT

BACKGROUND/OBJECTIVES: Reduced food intake, appetite loss and alteration of ghrelin and PYY(3-36) secretion have been suggested to have a function in the loss of body weight commonly observed after gastrectomy. The objective of this study was to investigate the circulating concentrations of ghrelin and PYY(3-36) and their relationships with food intake, appetite and resting energy expenditure (REE) after gastrectomy plus vagotomy. SUBJECTS/METHODS: Seven patients with total gastrectomy (TG), 14 with partial gastrectomy (PG) and 10 healthy controls were studied. Habitual food intake and REE was assessed; fasting and postprandial plasma total ghrelin, PYY(3-36) concentrations and appetite ratings were determined after ingestion of a liquid test meal. RESULTS: Differently from PG and controls, fasting ghrelin correlated with REE, and a higher energy intake was observed in the TG group. Fasting plasma ghrelin concentrations were lower in TG compared with controls, and no ghrelin response to the meal was observed in either PG or TG. Fasting plasma PYY(3-36) concentrations were not different among the groups. There was an early and exaggerated postprandial rise in PYY(3-36) levels in both PG and TG groups, but not in controls. No effect of ghrelin or PYY(3-36) concentrations was observed on hunger, prospective consumption or fullness ratings. CONCLUSIONS: Total ghrelin and PYY(3-36) do not seem to be involved with appetite or energy intake regulation after gastrectomy plus vagotomy. Ghrelin secreted by sources other than stomach is likely to have a function in the long-term regulation of body weight after TG.


Subject(s)
Appetite , Basal Metabolism , Energy Intake , Gastrectomy , Ghrelin/blood , Peptide YY/blood , Vagotomy , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Postoperative Complications/blood , Young Adult
6.
Adv Physiol Educ ; 33(4): 343-8, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19948686

ABSTRACT

Current medical curricula devote scarce time for practical activities on digestive physiology, despite frequent misconceptions about dyspepsia and dysmotility phenomena. Thus, we designed a hands-on activity followed by a small-group discussion on gut motility. Male awake rats were randomly submitted to insulin, control, or hypertonic protocols. Insulin and control rats were gavage fed with 5% glucose solution, whereas hypertonic-fed rats were gavage fed with 50% glucose solution. Insulin treatment was performed 30 min before a meal. All meals (1.5 ml) contained an equal mass of phenol red dye. After 10, 15, or 20 min of meal gavage, rats were euthanized. Each subset consisted of six to eight rats. Dye recovery in the stomach and proximal, middle, and distal small intestine was measured by spectrophotometry, a safe and reliable method that can be performed by minimally trained students. In a separate group of rats, we used the same protocols except that the test meal contained (99m)Tc as a marker. Compared with control, the hypertonic meal delayed gastric emptying and gastrointestinal transit, whereas insulinic hypoglycemia accelerated them. The session helped engage our undergraduate students in observing and analyzing gut motor behavior. In conclusion, the fractional dye retention test can be used as a teaching tool to strengthen the understanding of basic physiopathological features of gastrointestinal motility.


Subject(s)
Education, Medical, Undergraduate/methods , Education, Medical, Undergraduate/standards , Gastrointestinal Motility/physiology , Learning , Students, Medical , Wakefulness/physiology , Animals , Humans , Learning/physiology , Male , Rats , Rats, Wistar
7.
Dig Dis Sci ; 54(3): 627-33, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18633707

ABSTRACT

In order to increase dietary folic acid intake and to improve nutritional status regarding folate by controlling homocysteine concentrations, ten patients with inflammatory bowel diseases (Crohn's disease in the colon and ulcerative colitis) received individualized nutritional guidance and were followed up as outpatients for 2 months. The following procedures were performed at the beginning of the study (T0), after 1 month (T1) and at the end of the study (T2): collection of anthropometric data (weight and height), dietary data (24 h diet recall), and blood under fasting condition for the determination of serum folic acid, homocysteine, C-reactive protein, and vitamin B12. Plasma folic acid deficiency was not detected but hyperhomocysteinemia was present in six individuals and C-reactive protein (CRP) was increased (>0.5 mg/dl) in seven patients. After the patients were instructed there was a significant increase in vitamin B6 intake (about 35%) and in folate intake (49.6%). Mean plasma levels of folic acid, homocysteine, and vitamin B12 did not change, but there was a significant decrease of CRP at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2. We conclude that the increased folate intake reported by this group of patients was not reflected in improved serum concentrations of folic acid and homocysteine. However, the guidelines for the patients probably induced them to choose a more adequate diet, providing nutrients that help control the inflammatory process.


Subject(s)
C-Reactive Protein/metabolism , Folic Acid/administration & dosage , Homocysteine/blood , Inflammatory Bowel Diseases/diet therapy , Adult , Anthropometry , Diet , Female , Humans , Inflammatory Bowel Diseases/blood , Male , Middle Aged , Nutritional Status , Vitamin B 12/blood , Young Adult
8.
Neurogastroenterol Motil ; 20(5): 471-8, 2008 May.
Article in English | MEDLINE | ID: mdl-18208481

ABSTRACT

Disturbed gastric contractility has been found in manometric studies in patients with gastro-oesophageal reflux disease (GORD), but the pathophysiological role of this abnormality is unclear. We aimed at assessing postprandial gastric antral contractions and its relationships with gastric emptying and gastro-oesophageal reflux in GORD patients. Fasted GORD patients (n = 13) and healthy volunteers (n = 13) ingested a liquid meal labelled with 72 MBq of 99mTechnetium-phytate. Gastric images were acquired every 10 min for 2 h, for measuring gastric emptying half time. Dynamic antral scintigraphy (one frame per second), performed for 4 min at 30-min intervals, allowed estimation of both mean dominant frequency and amplitude of antral contractions. In GORD patients (n = 10), acidic reflux episodes occurring 2 h after the ingestion of the same test meal were determined by ambulatory 24-h oesophageal pH monitoring. Gastric emptying was similar in GORD patients and controls (median; range: 82 min; 58-126 vs 80 min; 44-122 min; P = 0.38). Frequency of antral contractions was also similar in both groups (3.1 cpm; 2.8-3.6 vs 3.2 cpm; 2.4-3.8 cpm; P = 0.15). In GORD patients, amplitude of antral contractions was significantly higher than in controls (32.7%; 17-44%vs 23.3%; 16-43%; P = 0.01), and correlated positively with gastric emptying time (R(s) = 0.58; P = 0.03) and inversely with the number of reflux episodes (R(s) = -0.68; P = 0.02). Increased amplitude of postprandial gastric antral contractions in GORD may comprise a compensatory mechanism against delayed gastric emptying and a defensive factor against acidic gastro-oesophageal reflux.


Subject(s)
Gastroesophageal Reflux/diagnostic imaging , Gastroesophageal Reflux/physiopathology , Muscle Contraction/physiology , Postprandial Period/physiology , Pyloric Antrum/diagnostic imaging , Pyloric Antrum/physiology , Adolescent , Adult , Female , Gastric Emptying/physiology , Humans , Male , Middle Aged , Peristalsis/physiology , Radionuclide Imaging/methods , Stomach/diagnostic imaging , Stomach/physiology
9.
Neurogastroenterol Motil ; 19(3): 225-32, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17300293

ABSTRACT

We evaluated the effects of cyclooxygenase-2 (COX-2) selective inhibitors, COX-1 selective inhibitor, or COX non-selective inhibitor on gastric emptying and intestinal transit of liquids, and evaluated the effect of a COX-2 selective inhibitor on gastric tonus (GT). Male Wistar rats were treated per os with saline (control), rofecoxib, celecoxib, ketorolac, rofecoxib + ketorolac, celecoxib + ketorolac, or indomethacin. After 1 h, rats were gavage-fed (1.5 mL) with the test meal (5% glucose solution with 0.05 g mL(-1) phenol red) and killed 10, 20 or 30 min later. Gastric, proximal, medial or distal small intestine dye recovery (GDR and IDR, respectively) were measured by spectrophotometry. The animals of the other group were treated with i.v. valdecoxib or saline, and GT was continuously observed for 120 min using a pletismomether system. Compared with the control group, treatment with COX-2 inhibitors, alone or with ketocolac, as well as with indomethacin increased GDR (P < 0.05) at 10-, 20- or 30-min postprandial intervals. Ketorolac alone did not change the GDR, but increased the proximal IDR (P < 0.05) at 10 min, and decreased medial IDR (P < 0.05) at 10 and 20 min. Valdecoxib increased (P < 0.01) GT 60, 80 and 100 min after administration. In conclusion, COX-2 inhibition delayed the gastric emptying of liquids and increased GT in rats.


Subject(s)
Cyclooxygenase 2 Inhibitors/pharmacology , Gastric Emptying/drug effects , Muscle, Smooth/drug effects , Stomach/drug effects , Animals , Celecoxib , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Indomethacin/pharmacology , Isoxazoles/pharmacology , Ketorolac/pharmacology , Lactones/pharmacology , Male , Pyrazoles/pharmacology , Rats , Rats, Wistar , Stomach/pathology , Sulfonamides/pharmacology , Sulfones/pharmacology
10.
Braz J Med Biol Res ; 38(9): 1375-82, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16138221

ABSTRACT

Patients with gastroesophageal reflux disease may have disturbances of gastric motility, which could play a role in the pathophysiology of the disease. Recent studies have suggested that the gastric region just below the gastroesophageal junction may have a distinct physiological behavior. We determined whether patients with gastroesophageal reflux disease have abnormal residence of food in the infra-junctional portion of the stomach after ingesting a liquid nutrient meal. Fasted adult patients with reflux disease (N = 11) and healthy volunteers (N = 10) ingested a liquid meal (320 ml; 437 kcal) labeled with 99m technetium-phytate and their total gastric emptying half-time and regional emptying from the stomach infra-junctional region were determined. In 8 patients, episodes of postprandial acidic reflux to the esophagus were measured for 2 h using pH monitoring. There were no differences between reflux patients and controls regarding total gastric emptying time (median: 68 min; range: 39-123 min vs 65 min and 60-99 min, respectively; P > 0.50). Food residence in the infra-junctional area was similar for patients and controls: 23% (range: 20-30) vs 27% (range: 19-30%; P = 0.28) and emptying from this area paralleled total gastric emptying (Rs = 0.79; P = 0.04). There was no correlation between residence of food in the infra-junctional area and episodes of gastroesophageal reflux (Rs = 0.06; P = 0.88). We conclude that it is unlikely that regional motor disturbances involving the infra-junctional region of the stomach play a relevant role in the pathogenesis of acidic gastroesophageal reflux.


Subject(s)
Esophagogastric Junction/physiopathology , Gastric Emptying/physiology , Gastroesophageal Reflux/physiopathology , Adult , Case-Control Studies , Esophagogastric Junction/diagnostic imaging , Female , Gastroesophageal Reflux/diagnostic imaging , Gastroesophageal Reflux/etiology , Gastrointestinal Motility/physiology , Humans , Hydrogen-Ion Concentration , Male , Middle Aged , Organotechnetium Compounds , Phytic Acid , Radionuclide Imaging , Time Factors
11.
Braz. j. med. biol. res ; 38(9): 1375-1382, Sept. 2005. tab, graf
Article in English | LILACS | ID: lil-408365

ABSTRACT

Patients with gastroesophageal reflux disease may have disturbances of gastric motility, which could play a role in the pathophysiology of the disease. Recent studies have suggested that the gastric region just below the gastroesophageal junction may have a distinct physiological behavior. We determined whether patients with gastroesophageal reflux disease have abnormal residence of food in the infra-junctional portion of the stomach after ingesting a liquid nutrient meal. Fasted adult patients with reflux disease (N = 11) and healthy volunteers (N = 10) ingested a liquid meal (320 ml; 437 kcal) labeled with 99m technetium-phytate and their total gastric emptying half-time and regional emptying from the stomach infra-junctional region were determined. In 8 patients, episodes of postprandial acidic reflux to the esophagus were measured for 2 h using pH monitoring. There were no differences between reflux patients and controls regarding total gastric emptying time (median: 68 min; range: 39-123 min vs 65 min and 60-99 min, respectively; P > 0.50). Food residence in the infra-junctional area was similar for patients and controls: 23 percent (range: 20-30) vs 27 percent (range: 19-30 percent; P = 0.28) and emptying from this area paralleled total gastric emptying (Rs = 0.79; P = 0.04). There was no correlation between residence of food in the infra-junctional area and episodes of gastroesophageal reflux (Rs = 0.06; P = 0.88). We conclude that it is unlikely that regional motor disturbances involving the infra-junctional region of the stomach play a relevant role in the pathogenesis of acidic gastroesophageal reflux.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Esophagogastric Junction/physiopathology , Gastric Emptying/physiology , Gastroesophageal Reflux/physiopathology , Case-Control Studies , Esophagogastric Junction , Gastroesophageal Reflux/etiology , Gastroesophageal Reflux , Gastrointestinal Motility/physiology , Hydrogen-Ion Concentration , Organotechnetium Compounds , Phytic Acid , Time Factors
12.
Conf Proc IEEE Eng Med Biol Soc ; 2005: 1382-4, 2005.
Article in English | MEDLINE | ID: mdl-17282455

ABSTRACT

A natural magnetic resonance imaging (MRI) contrast based on the pulp of a fruit "Euterpe Olerácea", popularly known as Açaí, was investigated. T1 and T2 contrasted images shown the effects of the contrast agent increasing the ability to visualize the contour of segments of the gastrointestinal tract.

13.
Braz. j. med. biol. res ; 37(1): 47-53, Jan. 2004. tab
Article in English | LILACS | ID: lil-352097

ABSTRACT

Gastric dysrhythmias, such as tachy- or bradygastria, have been reported in patients with functional dyspepsia (FD), but their role in symptom production is uncertain. It is also not known whether gastric dysrhythmias in these patients can be elicited by physiological gastric distension with a meal. We investigated the relationships between symptoms after ingestion of different volumes of water following a test meal and gastric dysrhythmias in FD patients. Fourteen patients with dysmotility-like FD and 13 healthy volunteers underwent paired electrogastrography (EGG) studies. Fasted subjects ingested 150 ml of yoghurt with either 150 ml (low volume) or 300 ml (high volume) water in random order. Fasting and fed EGGs with monitoring of symptoms were performed in both studies. Ten FD patients (71.4 percent) reported upper abdominal discomfort and bloating after the low volume meal, but only one (7.1 percent) presented an abnormal EGG (dominant frequency in the 2-4-cpm range: 58 percent). Following the high volume meal, 7 patients (50 percent) had symptoms, but none had EGG abnormalities. No significant differences were found between FD patients and controls for any of the EGG variables, in any test. In FD patients with postprandial symptoms, the percentage of the EGG dominant frequency in the normal range (median, 84.6 percent; range, 76.0-100.0 percent) was similar (P > 0.20) to that in those without symptoms (88.5 percent; 75.0-100.0 percent). We conclude that disturbances of gastric myoelectrical activity are unlikely to play a role in the origin of postprandial upper abdominal discomfort and bloating in dysmotility-like FD.


Subject(s)
Middle Aged , Humans , Male , Female , Adult , Dyspepsia , Gastric Emptying , Myoelectric Complex, Migrating , Postprandial Period , Stomach , Case-Control Studies , Electrodiagnosis
14.
Braz J Med Biol Res ; 37(1): 47-53, 2004 01.
Article in English | MEDLINE | ID: mdl-14689043

ABSTRACT

Gastric dysrhythmias, such as tachy- or bradygastria, have been reported in patients with functional dyspepsia (FD), but their role in symptom production is uncertain. It is also not known whether gastric dysrhythmias in these patients can be elicited by physiological gastric distension with a meal. We investigated the relationships between symptoms after ingestion of different volumes of water following a test meal and gastric dysrhythmias in FD patients. Fourteen patients with dysmotility-like FD and 13 healthy volunteers underwent paired electrogastrography (EGG) studies. Fasted subjects ingested 150 ml of yoghurt with either 150 ml (low volume) or 300 ml (high volume) water in random order. Fasting and fed EGGs with monitoring of symptoms were performed in both studies. Ten FD patients (71.4%) reported upper abdominal discomfort and bloating after the low volume meal, but only one (7.1%) presented an abnormal EGG (dominant frequency in the 2-4-cpm range: 58%). Following the high volume meal, 7 patients (50%) had symptoms, but none had EGG abnormalities. No significant differences were found between FD patients and controls for any of the EGG variables, in any test. In FD patients with postprandial symptoms, the percentage of the EGG dominant frequency in the normal range (median, 84.6%; range, 76.0-100.0%) was similar (P>0.20) to that in those without symptoms (88.5%; 75.0-100.0%). We conclude that disturbances of gastric myoelectrical activity are unlikely to play a role in the origin of postprandial upper abdominal discomfort and bloating in dysmotility-like FD.


Subject(s)
Dyspepsia/physiopathology , Gastric Emptying/physiology , Myoelectric Complex, Migrating/physiology , Postprandial Period/physiology , Stomach/physiopathology , Adult , Case-Control Studies , Electrodiagnosis , Female , Humans , Male , Middle Aged
15.
Braz. j. med. biol. res ; 36(10): 1383-1390, Oct. 2003. ilus
Article in English | LILACS | ID: lil-346491

ABSTRACT

Gastric antral dysmotility has been implicated in the pathogenesis of indomethacin-induced gastric damage, but the relationship between gastric motor abnormalities and mucosal lesions has not been extensively studied. We investigated whether changes in gastric tone and gastric retention correlate with mucosal lesions and neutrophil migration in indomethacin-induced gastric damage in rats. Indomethacin, either 5 or 20 mg/kg (INDO-5 and INDO-20), was instilled into the stomach, and then gastric damage, neutrophil migration, gastric tone and gastric retention were assessed 1 or 3 h later. Gastric damage was calculated as the sum of the lengths of all mucosal lesions, and neutrophil migration was measured by assaying myeloperoxidase activity. Gastric tone was determined by a plethysmometric method, and gastric retention of either saline or Sustacal« was evaluated by a scintigraphic method. Gastric damage was detectable 3 h after either INDO-5 or INDO-20, but not after 1 h. Neutrophil migration was significantly higher 3 h after INDO-20 as compared with INDO-5 or control group, but not after 1 h. Values of gastric tone 1 and 3 h after either INDO-5 (1 h = 1.73 ± 0.07 ml; 3 h = 1.87 ± 0.03 ml) or INDO-20 (1 h = 1.70 ± 0.02 ml; 3 h = 1.79 ± 0.03 ml) were significantly lower than in controls (1 h = 1.48 ± 0.05 ml; 3 h = 1.60 ± 0.06 ml). Gastric retention of saline was higher 1 h after INDO-5 (58.9 ± 3.3 percent) or INDO-20 (56.1 ± 3.1 percent) compared to control (45.5 ± 1.7 percent), but not after 3 h. There were no differences concerning gastric retention of Sustacal« between the various groups. Indomethacin induced decreased gastric tone and delayed gastric emptying, which precede mucosal lesion and neutrophil infiltration. These results indicate that there is no relationship between these gastric motor abnormalities and mucosal lesion in indomethacin-induced gastropathy


Subject(s)
Animals , Male , Rats , Anti-Inflammatory Agents, Non-Steroidal , Gastric Emptying , Gastric Mucosa , Indomethacin , Neutrophil Infiltration , Muscle Tonus , Rats, Wistar
16.
Braz J Med Biol Res ; 36(10): 1383-90, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14502371

ABSTRACT

Gastric antral dysmotility has been implicated in the pathogenesis of indomethacin-induced gastric damage, but the relationship between gastric motor abnormalities and mucosal lesions has not been extensively studied. We investigated whether changes in gastric tone and gastric retention correlate with mucosal lesions and neutrophil migration in indomethacin-induced gastric damage in rats. Indomethacin, either 5 or 20 mg/kg (INDO-5 and INDO-20), was instilled into the stomach, and then gastric damage, neutrophil migration, gastric tone and gastric retention were assessed 1 or 3 h later. Gastric damage was calculated as the sum of the lengths of all mucosal lesions, and neutrophil migration was measured by assaying myeloperoxidase activity. Gastric tone was determined by a plethysmometric method, and gastric retention of either saline or Sustacal was evaluated by a scintigraphic method. Gastric damage was detectable 3 h after either INDO-5 or INDO-20, but not after 1 h. Neutrophil migration was significantly higher 3 h after INDO-20 as compared with INDO-5 or control group, but not after 1 h. Values of gastric tone 1 and 3 h after either INDO-5 (1 h = 1.73+/-0.07 ml; 3 h = 1.87+/-0.03 ml) or INDO-20 (1 h = 1.70+/-0.02 ml; 3 h = 1.79+/-0.03 ml) were significantly lower than in controls (1 h = 1.48+/-0.05 ml; 3 h = 1.60+/-0.06 ml). Gastric retention of saline was higher 1 h after INDO-5 (58.9+/-3.3%) or INDO-20 (56.1+/-3.1%) compared to control (45.5+/-1.7%), but not after 3 h. There were no differences concerning gastric retention of Sustacal between the various groups. Indomethacin induced decreased gastric tone and delayed gastric emptying, which precede mucosal lesion and neutrophil infiltration. These results indicate that there is no relationship between these gastric motor abnormalities and mucosal lesion in indomethacin-induced gastropathy.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Gastric Emptying/drug effects , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Indomethacin/pharmacology , Neutrophil Infiltration/drug effects , Animals , Male , Muscle Tonus/drug effects , Rats , Rats, Wistar
17.
APMIS ; 110(11): 795-801, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12588420

ABSTRACT

AIM: In the present study we evaluated the effects of gastric myenteric denervation using benzalkonium chloride (BAC) on the time for gastric emptying, as well as gastric secretion, and mucosal epithelial cell size and population in rats. METHODS AND RESULTS: Wistar rats were treated with topical serosal application of BAC to the stomach. Control animals received saline. Ninety days after surgery, gastric emptying time, gastric acid secretion and serum gastrin levels were studied. Next, the animals were sacrificed and the stomachs were removed, fixed in formalin and histologically processed for histomorphometry of the height, area and volume of the glandular portion, and volume and population of mucous, chief, parietal, G- and labelled cells. BAC animals showed a significant delay in gastric emptying and an increase in gastric acid secretion and serum gastrin levels. These animals also presented a significant reduction of myenteric neuron number, hypertrophy of parietal and chief cells, hyperplasia of G cells and an increase in the gastric mucosa area. CONCLUSION: The absence of the myenteric plexus seems to protect the stomach from the hyperplastic effects of hypergastrinemia. Gastric food stasis may act as a factor triggering morphological and functional alterations of the gastric epithelium. Although gastric food stasis is a common finding in medical practice, its physiopathological consequences are poorly understood and have not been frequently discussed in the literature.


Subject(s)
Gastric Emptying , Gastric Mucosa/physiology , Gastrins/blood , Stomach/physiology , Animals , Benzalkonium Compounds , Chief Cells, Gastric/pathology , Detergents , Gastric Acid/metabolism , Gastric Acidity Determination , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Gastrin-Secreting Cells/pathology , Hyperplasia , Muscle Denervation/methods , Muscle, Smooth/innervation , Muscle, Smooth/physiology , Myenteric Plexus/drug effects , Organ Size , Parietal Cells, Gastric/pathology , Rats , Rats, Wistar , Stomach/innervation
18.
Rev Assoc Med Bras (1992) ; 47(2): 157-64, 2001.
Article in Portuguese | MEDLINE | ID: mdl-11468684

ABSTRACT

PURPOSE: To determine the frequencies of digestive symptoms in an unselected sample of Brazilian diabetics, in comparison to those verified in the general population. METHODS: The frequencies of 13 digestive symptoms were determined in 153 type 1 and type 2 diabetics and in 50 apparently healthy controls, utilizing a structured, standardized questionnaire. RESULTS: The percentage of diabetics with at least one symptom was significantly higher than in controls (70% vs 36%, p = 0.01). Higher frequencies of upper digestive symptoms, such as postprandial epigastric fullness (30% vs 35%), heartburn (30% vs 34%), as well as constipation (17% vs 12%) were observed in both groups. Nevertheless, only the prevalence of dysphagia (13% vs 2%) was significantly increased (p = 0.02) in diabetics. CONCLUSION: These findings indicate that gastrointestinal symptoms are common in diabetics, but this seems also to be the case in the general population, with the exception of dysphagia. The frequencies of symptoms observed in Brazil were similar to those reported in studies from the North Hemisphere, a finding that does not support the hypothesis that external factors may influence the prevalence of gastrointestinal symptoms in diabetics.


Subject(s)
Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Gastrointestinal Diseases/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Brazil/epidemiology , Case-Control Studies , Diabetes Mellitus, Type 1/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Female , Gastrointestinal Diseases/epidemiology , Humans , Male , Middle Aged , Odds Ratio , Surveys and Questionnaires
19.
Rev. Assoc. Med. Bras. (1992, Impr.) ; 47(2): 157-164, abr.-jun. 2001. tab, graf
Article in Portuguese | LILACS, Sec. Est. Saúde SP | ID: lil-305138

ABSTRACT

Sintomas sugestivos do comprometimento do tubo digestivo säo comuns em pacientes diabéticos, mas estudos comparando as freqüências destes sintomas com as da populaçäo geral säo escassos e näo existem trabalhos dessa natureza com diabéticos brasileiros. OBJETIVO: Determinar as freqüências de diferentes sintomas digestivos em amostra näo selecionada de pacientes diabéticos, em comparaçäo às encontradas em pessoas da comunidade. MÉTODOS: A ocorrência de 13 diferentes sintomas digestivos foi investigada por meio da aplicaçäo de um questionário padronizado, especificamente estruturado, em 153 diabéticos dos tipos 1 e 2 e em 50 pessoas aparentemente sadias, tomadas como controles. RESULTADOS: A freqüência de diabéticos com pelo menos um sintoma digestivo foi significativamente superior à verificada no grupo controle (70 por cento vs 36 por cento, p = 0,01). Freqüências elevadas de plenitude gástrica (30 por cento vs 36 por cento), pirose (30 por cento vs 34 por cento) e de constipaçäo (17 por cento vs 12 por cento), foram observadas tanto entre os diabéticos como nos controles. No entanto, somente a freqüência de um único sintoma, a disfagia, foi significativamente maior entre os diabéticos, em relaçäo ao grupo controle (13 por cento vs 2 por cento, p = 0,02). CONCLUSÄO: Estes resultados indicam que a freqüência de sintomas digestivos em diabéticos, apesar de elevada, näo difere da verificada na populaçäo geral, exceto para a disfagia. As freqüências dos diferentes sintomas estiveram próximas das faixas relatadas em estudos do hemisfério Norte, o que näo apóia a hipótese de que fatores inerentes ao meio afetam a ocorrência de queixas digestivas em diabéticos.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Diabetes Mellitus, Type 1 , Gastrointestinal Diseases , Aged, 80 and over , Brazil , Case-Control Studies , Odds Ratio , Surveys and Questionnaires , Diabetes Mellitus, Type 1
20.
Arq Gastroenterol ; 38(3): 207-12, 2001.
Article in Portuguese | MEDLINE | ID: mdl-11917722

ABSTRACT

BACKGROUND: Functional dyspepsia is defined by upper gastrointestinal symptoms without any evidence of structural abnormalities or organic disease. Current pharmacological treatment of functional dyspepsia is largely empirical and involves anti-secretory or prokinetic drugs. AIMS: To review recent advances in the understanding of the mechanisms involved in symptom production in functional dyspepsia, as well as the development of new drugs that may interfere with these mechanisms, which may lead to more rational and effective treatment of this clinical condition. METHOD: Systematic review of papers published in English for the last 10 years. RESULTS: New drugs that increase propulsive gastroduodenal motor activity include new benzamides similar to cisapride, CCK-A blockers, agonists of opiate receptors and motilin agonists similar to erythromycin. A number of agents, including sumatriptan and buspirone, stimulates serotonin receptors in the myoenteric plexuses and have been shown to increase gastric accommodation to a meal. Finally, a number of new drugs that either increase thresholds for visceral perception or modify sensations is currently under investigation. This includes agents of several groups, such as octreotide, loxiglumide, ondansetron and other serotonin blockers, fedotozine and tricyclic antidepressant at low doses. CONCLUSIONS: Although these new drugs may improve the pharmacological approach to the treatment of functional dyspepsia, there is a need for randomized, controlled trials to assess their efficacy. Moreover, difficulties related to the identification of the mechanisms underlying symptoms may limit the utilization of these new drugs.


Subject(s)
Dyspepsia/drug therapy , Gastrointestinal Agents/therapeutic use , Dyspepsia/physiopathology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...